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INTRODUCTION 
End9toxins are intracellular substances liberated by 
bacterial disintegration (10, 50). Endotoxin shock can 
occur clinically in man as a consequence of bacteremias 
(3, 7) and experimentally in manunals by intravenously in-
jecting endotoxin, The mechanism by which endotoxin.produces 
shock is exceedingly complex (15, 17, 30, 31, 34, 35, 48). 
The initial reaction to injected endotoxin is a severe drop 
in blood pressure with a concurrent decrease in central 
venous return. This first hypotensive phase is correlated 
to either a pooling of blood in the liver or a decrease in 
cardiac output. The initial·hypotension is followed by a 
return within thirty minutes of arterial pressure toward 
normal levels. In one to two hours a second gecrease in .. 
systemic arterial blood pressure occurs followed by a 
vascular loss of plasma and a progressive hemoconcentration. 
The second hypotensive phase occurs when blood pools mainly 
in the splanchnic bed. 
Choline chloride is a vasopressor drug which may be of 
therapeutic value in. treating endotoxin shock. Mitchell 
(32) demonstrated some of its systemic effects· following 
intravenous injection into normal mongrel dogs. Choline 
Chloride increased the left ventr.icular systolic pressure in 
the. heart. The ability of choline chloride to raise left 
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ventricular pressure may be explained by an.increase in the 
force of cardiac. contraction. The: systemic arterial blood 
pressure is increas'ed by choline chloride. Mi:tchell postu-. 
lated·that the increase.in systemi'? arterial blood p:essure 
was caused by the cardiac-stimulating ability.of the drug 
and not by vasoconstriction. Unlike many vasopressor dri,igs, 
choline chloride produces its cardiac-stimulatin~ response 
without producing extrasystoles or other cardiac arrhythmias. 
Furthermore, the respiratory rate is stimulated. by choline· 
chloride. 
Engen (11) observed that choline chloride reversed the 
hypotensive e:ffects of intravenously .injected histamine. 
After histamine administration, the drop in arterial blood 
pr.essure returned to' near normai ·values. after choline chloride 
injections. 
The effects produced in normal dogs after intravenous 
injection of choline chloride suggest that it may be an 
effective therapeutic agent for endotoxin shock.. To demon:-
strate this, experimental shock was produced in dogs with 
E. coli endotoxin. 
The objective of this study was to determine the ef-
ficiency of choline chloride in reversing the signs of endo-
toxin shock .and ip.c;reasing survival rates following adm:i:n~ 
is tration of . lethal' do.~es of', endotoxin. 
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LITERATURE REVIEW 
Gram-negative bacteriemias·were recognized. early in 
the 19th century (42). ·Laennec (23) in 1831 artd Boi.se (8) 
in 1897 described c;:irculatory failure occurring wit;h 
bacterial infection. In 1943, Fine apd s.aligman (13) oJ:?-
served that patients with overwhelming bacterial· infections .. 
such as those fro.m. coli-form organisms in the peritoneal· 
cavity, female reproductive .. organs, or the urinary tract were 
similar to patients with traumatic shock. In 1945, Aub., 
et al. (2) discovered that the muscle fluid from an is chemic -- . 
canine muscle contained toxins that produced shock in test 
animals. The endotoxins were of anaerobic organisms. In 
1951, Waisbren. (42) described two clinical pictures· with 
gram-negative bacteremias whi'ch had .the gross·,:appearance· of 
toxicosis and shock. 
Endotoxin shock caused by a bacteremia is a predominant 
problem in human medicine (3, 7) and is a known problem in 
canine medicine (22) • The de.ath rate of patients that. develop 
endotoxin shock from bacteremia ranges between 50% to 80% (49). 
Bacterial endotoxin shock may occur in humans with urinary 
tract and pneumonic infection and in dogs with peritonitis, 
acute metritis, and certain acute enteric and .urinary tract 
infections. Gram-negative bacte.ria seem to be the most 
common etiologic agents, including: Escherichia coli, 
Ps.eudomonas .aerugiriosa,· Br.uce.11·a':me'l.:i t·ensis, ,Salmonella 
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typhosa, and serratia.marcescens (.3, 7, 22). 
. . 
Endotoxins are intracellular substances lib.erated by 
bacterial disintegration.. They constitute a relatively 
homogenous group of substances that exist as protein-poly-
saccharide-lipid complexes in the cell. . Toxicity ha!? be.en 
associated with.phosphorous containing nitrogenous· sub-
stances that make up a relatively small part of the complex. 
The endoto"xin complex ·is highly antigenic but the toxicity 
is not effectively neutralized. by antibody (10, 51). 
The mechanism by which endotoxin produces shock is 
exceedingly complex anq many views exist as to the importance 
of each of the responses reioulting from endotoxin administr~­
tion. There is a definite· patte.rn of hemodynamic events 
and hemodynamical·ly related events which occur after intra·-
venous endotoxin injection. The initial reaction-in the dog 
is usually a rapid drop in systemic blood pressure with a 
concurrent decrease in central venous return (46). The 
decreased blood pressure and venous return may be caused by a 
rapid pooling of blood in the liver as a result of transient 
hepatic venous constriction produced by histamine release 
(17, 30, 31). Rosenberg, et al. (34) suggested 'that the 
initial decrease in cardiac- output arose from an acute car 
pulmonale produced by the occlusion of pulmonary capillaries 
by vasospasm. This: could .. p~rmi t" damming cif blood in the 
portal system.-
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The initial hypotension is usually followed by a return 
of_ arteri_al pressure toward normal, levels,· usually with.in 
thirty minutes. This may be explained by the release of 
pooled blood from the live_r and an increase in catecholamine 
levels stimulated by. the barorecieptor reflex (15, 31, 34, 35). 
Within one to two hours of the original intravenous injection 
of endotoxin the arterial blood pressure drops again. The· 
final prolonged hypotension results from a peripheral pooling 
of blood with the vasculaturei of the small intestine .con-
taining the greatest volume of blood (17, 31, 46). During 
the later part of the second hypotensive phase, there is a 
loss of plasma and a progressive hemoconcentration (25, 
48). Microcirculation at this time ·is characterized by 
dilated arteriolar sphincters and congested capillaries (26). 
The mucosa of the bowel becomes congested and a transudate 
which is first clear and then bloody collects in the lumen. 
There may be a bloody diarrhea presumably caus_ed by the 
necrosis and sloughing of the intestinal mucosa as the re-
sult of intravascular clotting, ischemia, and anoxia (12). 
Electrocardiographic recordings taken during experi-
mentally produced endotoxin shock reveal three abnormalities: 
a reduction in voltage in the R wave with a prominent T wave .,. 
elevation (ll); ST· segmental depressions (l, 12); and terminal 
arrythmias (12) • The heart and respiratory rates of dogs in 
endotoxin shock are variable (12, 43). 
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Metabolic acidosis develops during the secondary hypo-
tens i ve phase. The intensity of acidosis is .. related t;o 
the hemoconcentration and hypotension ·(JB, 47, 48). Oliguria 
or anuria which occur during the second hypotens.ive phase 
are produced by a reflex renal vasoconstriction and ·also 
the hypotensive state. Decreased renal .filtration enhances 
acidosis (12, 36, 38) • 
After blood is pooled, additional patholo.gical events 
develop which, if untreated, lead to irreversible shock. 
Hardaway (14) demonstrated a hypercoagulability .of the blood 
and the formation of microthrombi. in the peripheral circu-
lation. He suggested that this physj.cal obstruction to the 
flow of blood in addition to intense vasoconstriction might 
account for ·the death of vital tissues and thereby cause 
irreversible shock. Evangelista, et al. (12) demonstrated 
that plugging of mucosal capillaries by clots occurred 
during the second hypotensive phase. Robb (33) observed 
that platelet microembolism occurs in animals during endo-
toxin shock and that embolic occlusion of the hepatic circu-
lation could account for damming of blood in the portal 
system. 
Although the exact role of endogenous vasoactive agents 
in the development of irreversible shock has not been es-
.. 
tablished, they may be related to the peripheral pooling of 
blood (4). Lillehei and MacLean (29) reported that ve11sels in 
·' 
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the bowel mes'entery constricted until they were scarcely 
v:i,.si°ble following ·an ·intravenous injection Of !• coli e11do-. 
" toxin. Prior in]ections of the alpha adrenergic blockers, 
ch.lorpromazine and dibepzyline were effective in pre-. 
venting shock (27, ·2a) •. Lillehei, et al. (26) examined 
the· microculation in the viscera of dogs and found the 
arterioles and venules .in vasospasm. Splanchnic organs 
suffered profound decrease in arterial blood fiow. Siegel, 
et al. (37) observed that precapillary artl1!riolar vaso-
constricti9n occurred late after intravenous endotoxin in-
jection and was manifested by P.arallel capillary resistances 
of low value. In contrast to normal shunting over which 
some degree of S,Ympathomimetic control exists, there was a 
relative paralysis of regulatory control over shunts •. The 
degree of arteriovenous shunt].ng was then a· passive co.nse-
quence of the increase in flow ~nd the presumable cause' of 
the pooling of blood. 
Lillehei, et al. (26) proposed a theoretical sequence 
of events to be common to hypovolemic, neurologic, and septic 
shock. At the onset of severe hypotension, there is an 
increase in secretion of corticosteroids and epinephrine 
from the adrenal gland. There is increased sympathetic nerve 
activity which liberates norepinephrine at the myoneural 
junctions, which causes an intense vasoconstriction at the 
pre capillary arteriolar sphincters in the vis·cera; . the' skin 
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and to a lesser extent in the muscles. The purpose of this 
is to preserve blood flow to the brain'and to the heart. ThE! 
cerebral and coronary circulatory systems are not stron'gly 
effected by catecholamines. The affected tissues. are pale 
and almost bloodless. This phase may be reversed 'by prompt 
use of .fluid therapy to restore the normal circulatory 
dynamics •. If shock is prolonged the.situation progresses 
because of anoxia of tissues .and accumulation of metabolic 
products, which _leads to acidosis. Thus, sympathomimetic 
amines must be secreted in greater amounts to produce the 
same effects. '1.f these conditions of shock. prevail for a 
long period, the venule sphincters maintain tone but the 
arteriole sphincters do not. With the loss of arteriole 
sphincter constriction, blood passes into the capillary 
beds in increased amounts but cannot escape. The hydro-
static pressure in the capillaries increases above the 
.colloid osmotic pressure and fluid is forced from the vascu..: 
lature • As stagnation proceeds, capillaries lose integri.ty, 
allowing whole blood to .suffuse into the tissues. This'is 
the point of irreversible shock. 
It has been questioned whether the alteration in cardiac 
performance results from a direct depressant effect of 
endotoxin on the heart or the hypotension. Weil, et al. 
(46) reported that in the hypotensive state of endotoxin 
shock there was a fall of 21% to 36% in the cardiac· output •. 
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However, the inferior.verta ca.va pressure was unaffected, 
indicating that the fall in cardiac output could not be ' 
attributed to congestive heart :failure·, They suggested· 
that pooling decreased venous return and in turn cardiac' 
output. 
Siegel and E:abian (36) reported that.endotoxin 
depressed the myocardium in·normal dogs and also in dogs 
with baroreceptor and chemoreceptor afferent nerves and·vagal 
sympathetics sectioned. A decrease in contractility occurred 
before a substantial drop in arterial blood pressure ·and was 
progressive in all denervated animals which could not elicit 
reflexed contractili ty. Slow intravenous infusion o-f nor-
epinephrine. isoproterenol caused a marked reversal of the 
negative inotropic effect, without a substantial increase, in 
the blood pressure.· When isoproterenol was, discontinued; 
contractility decreased to the level produced by endotoxin. 
Starzecki and Spink (40) measured myocardial function 
and peripheral hemodynamic alterations in late stages of 
experimentally produced endotoxin shock in dogs. Analysis of 
the left ventricular functional curves indicatea a decre·!ised 
myocardial contractility with progressive rise in left 
ventricular end diastolic pressure, a rise_ in central venous 
pressure, and a declining arterial blood pressure. Their 
Observation suggested that the mechanism Of death is primarily 
of· cardiac origin at the terminci.1" st.ages of 'endotoxin: sh6_ck. 
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wangensteen, et· al • .(4·3) .. a:nd Lefer '(25) · ·sugg ..es'te·d that 
reduced.splanchnic blood flow occurring during shock, in;.. 
eluding endotoxi!\ shock, was the triggering cause: for·fhe 
production of .a my.ocardial·depressant factor. 
, ., : r; •. -
A' reduced·· 
splanchnic blood ·flow caused the release of' proteases frC)m 
the splanchnic organs.. Proteas,ef! are carried to the blood 
vasculature via the lymphatics -ii:nd produce the"myoc·ardial 
depressant factor from blood- proteins. 
Histamine produce·s vasodilatiori' by a direct ·action on 
small blood vessels and has·been 'implicated ·in· the hypo-
tensive state ·of endotoxin shock. ·we.il and Spink '(50) 
injected. intravenously ~·· ·coli eridotoxin· into dogs·. His·ta-
mine was detected in plasma samples within one' or two"minutes 
after the ·.injection of endotoxin·.. Elevated· h:i'stamiJ1e· con~ 
centrations coincided with the second precipitous fall in 
the arterial blood .pressure, 
Hinshaw, et al. (18) reported that plasma histamine 
concentrations increased after ~- coli endotoxin injection. 
After an initial transient decrease, whole blood.histamine 
concentrations increa·sed and remained· elevated foliowing 
endotoxin injection. 
Hinshaw, et al. (16) conducted a comparative study. of 
hemodynamic actions of'histamine and endotoxin: "A hi~tamine 
releaser, histamine, arid ~· · coli endotoxin ·were. ·eii.cli .;_d-
ministered intravenously into dogs. All agents produced a 
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rapid decre<;iSe in . systemic arterial pressure and an early· 
increase in .portal venous pressure wh:i~h was'. coiri.bidental. . . . 
with a decrease in venous return. 
Hinstiaw, et al. (19) performed a series of-experiments 
by perfusing an isolated _dog's leg with blood f-rotn an intact 
dog in endotoxin shock. Vascular response of the perfused 
leg to presser agents appeared abnormal-in that· the small 
vein constriction was m6re prolonged than the arterial 
cons_triction. The isolated leg gained weight indicating 
that a collection or pooling of blood occurred. In late 
endotoxin shock, the arterial vasod:ilation response .to in-
jected histainine became progressively greater. ·-The ?uthors 
suggested that the· irreversible period of endotoxin shock 
could be a .combination of abnormal presser responses by 
the pre- and post-capil:l.ary segme:nts and the incre·~sed 
sensitization to histamine·. 
Vick (41) presented data t\"lat supports histamine as 
the "trigger" in the mechanism of. end9toxin shock.. He 
isolated saphenous veins and measured their contractile 
responses while .beingbath~d by plasma, platelets, and endo-
toxin. This ·combination produced a decreased contractile 
response ,which resembled that of histamine. Furthermore·, 
the response was biocked by antihistamines •. Vick concluded 
that endotoxin and some "required substance" in plasma 
combine to release histamine from. platelets. H:i:st'amirie may be 
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the· factor involved in the mechanism of' the ini:tial. hypo.-. 
tensive phase of endotoxin shock,_ 
. Weil and Miller (47) and Spink and Vick (38) adminis--· 
tered E. coli endcitoxin intravenously into anesthetized 
dogs. Metaraminol was i'nfused intravenously fifteen.minutes 
after the :injection. of E. coli .endotoxin. Metarami.noL main-
tained arterial blood pressure at near control levels and 
increased. the survival time by two to three ho~rs. 
Starzeck:i., et g. (40) intravenously injected dogs with 
various dosages of.E. coli e11dotoxin. One hou~ after in-
jection, isoproterenol was infused at a fixed rate over four 
hours. Isoproterenol reduced the mortality rates signi:fi-
cantly in all but. the greatest challenge doses.· 
Loeb, ·et al.· (29) demonstrated that dopamine was superior ,, -- . 
to either isoproterenol or·norepinephrine when treating ·human 
patients in- infectious shock. Dopamine exerts positive ino-
tropic and chronotropic .e.ffects similar to those of nor-
epinephrine. Dopamine, however, causes a nonadrene.rgic 
vasodilatation in. the mesenteric and renal vascular beds 
whereas norepinephrine c;:ause_s vasoconstriction. in these beds. 
Isoproterenol could· not sustain blood . pressure; b.ecause. of . 
t . . ' 
the widespread.vasodilatation produced in skin and skeletal 
muscle. Dopamine maintained mean arterial blood pressure 
in all but a few cases. Norepinephrine treatment resulted 
in higher mean arterial pressure than dopamine. . Mean urine 
13 
flow was similar with both agents. Because dopamine pro~ 
duced higher cardiac output· and lower left ventricular end 
dic:i.stolic pressure than norepinephrine, it was considered 
the more desirable of the two. 
Lansing and Hinshaw (24) treated dogs with dopamine, 
thirty. minutes prior to giving E.coli endotoxin. They ob-
served that dopamine increased cardiac output andthat this 
increase persisted during the post-endotoxin period. Systemic 
arterial pressure was supported only during the early'post-
endotoxin period. The increase in cardiac output was a func-
tion of an increase in venous return and a reduction.in 
peripheral resistance. Dopamine may have alpha'."adrenergic 
action in· the hepatic bed and beta-adrenergic action in.the 
extra hepatic· regions. This may prevent the pooling of blood 
and shunt the blood into extrahepatic regions.where vaso-
dilatation favors an increase in blood flow to .the posterior 
vena cava. The increase in cardiac output was a function 
of dopamine' s iriotropic an.a chronotropic effects. 
Starzecki and Spink (40) and Siegel and Fabian (36·) 
infused isoproterenol during late endotoxin.shock in dogs. 
Isoproterenol markedly improved myocardial function, stabil~ 
ized a declining arterial blood pr~ssure and slowed the 
heart.. The left ventricular end diastolic press.ure was 
also reduced with isoproterenol. 
Weil, et-al. (44) diverted blood in' dogs from 'the anterior 
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and posterior vena cava to a reservoir. The blood collected 
was pumped at a constant rate to the right atrium. When 
endotoxin shock was produced by inj·ecting ~· coli endotoxin. 
intravenously, a sharp decline in venous return occurred.· 
When the decline was established, metaraminol was injected 
intravenously. The initial dose was given three and one-
half minutes after the decline and supplementary doses 
were injected at one and one-half to eight-~inute intervals 
thereafter. Metaraminol promptly halted the decline in 
venous return and, in fact, slightly increased the venous 
return. The authors suggested that metaraminol stopped the 
early pooling of blood associated with the decline in venous 
return following injection of endotoxin. In similar experi-
ments using a variety of vasopressor agents, Weil, et al. 
(45) observed that angiotensin, methoxamine, phenylephrine 
and epinephrine elevated the arterial blood pressure and re-
duced the venous return. Metaraminol and norepinephrine 
elevated the arterial blood pressure and increased venous 
return. 
Many investigators believe that alpha-adrenergic stimu-
lation in the vascular beds should be blocked in an attempt 
to reverse the vascular abnormalities produced during endo-
toxin shock. The vasoconstriction produced is detrimental 
to adequate perfusion of vascular beds. Alpha-adrenergic 
blockers like phenoxybenzamine, chloropromazine, and di-
15 
benzyline.have been used with' beneficial effects (9, 20, 27, 
2 8) • 
Berk, et al. (5, 6) suggest that there may be excessive 
beta adrenergic stimulation during endotoxin shock. Dogs 
treated with propranolol hydrochloride, a beta-adrenergic 
blocker, showed increased survival rates correlating with 
improved parameters of tissue perfusion consistent with 
the closure of arteriovenous shunts. Human patients irt 
late septic shock which were refractory to conventional 
treatment showed improved hemodynamic patterns and increased 
survival rates when treated with propranolol. 
The mechanism by which endotoxin produces shock is 
exceedingly complex. The first hypotensive phase is corre-
lated to either a pooling ·Of blood in the liver or a de-
crease in cardiac output. The second hypotensive phase 
occurs when blood pools in the splanchnic bed. A direct 
depressant effect by endotoxin on the heart has also been 
suggested, as a cause of pooling. Vasoactive drugs have been 
used in efforts to reverse endotoxin shock. No single drug 
appears to be satisfactory, but dopamine and metaraminol 
have exhibited the most potential .for reversing endotoxin 
shock. 
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MATERIAL AND METHODS 
·Six control beagle dogs 9 to 12 months .. old were'. injected 
int.ravenously with Escherichia coli endotoxirt1 to indu~e endo-
toxin shock. A dosage of 1.54 mg/kg .produced severe 'shock 
and death in five of the dogs. The sixth dog survived 
despite sighs of severe shock. Two dogs were each'given 
'.· 
1.54 mg/kg of E. coli endotoxin and were infused with 
choline ·chloride in an effort to ·reverse the cardi9vascular 
hypotension. The infusion rate was to be adjusted to main-
tain a persistent elevation .near that of the control 
· arterial blood pressure. Four other dogs that received 
choline chloride were given. intravenous injections at either 
5.0 mg/kg or 10.0 mg/kg in an effort to maintain a .per-
sistent elevation near that of the control .arterial blood 
pressure. The intraveno12s injection dosages were reported 
by Mitchell ( 32) to prod12ce 'significant. e'levations in arterial 
blood pressure. 
Dogs were anesthetized with 2% sodium thiopental 
· (Dipentol) • 2 An endot:racheal tube was inse.rted ·and methoxy-
flurane (MetofaneJ 3 was administered in a Heidbrink 
1 . ' ' ' 
Difeo Laboratories, Detroit, Michigan; ·a. G. Coli: 
0/27:B8 • 
. 2niamond Laboratories, Inc., Des Moines, low.ii. 
3i?i.tman-Moore .Divi.si~n of the .now Chemical company,· 
Indianapolis, Indiana. 
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Veterinary Anesthesia Machine1 to maintain general anesthesia. 
A skin inci.sion was made posterior to. the larynx and 
1 cm lateral to the trachea; The sternohyoideus·muscle was 
bluntly separated from the sternomastoideus muscle which 
·exposed the carotid artery and vagosympathetic trunk •. The. 
vagosympathetic trunk was separated from the carotid artery • 
. The. carotid artery was catheterized with a 1 mm diameter 
poly-vinyl -catheter. A purse string suture with 2-0 silk 
was placed in the carotid artery around the catheter to 
prevent hemorrhage and to allow for closure of the vessel 
incision after removal of the catheter. 
Through the same skin incision, the jugular vein was 
' 2 . 
isolated and-.a 14 gauge indwelling catheter was inserted. 
A purse string suture with 2-0 silk was placed in the jugular 
vein around the catheter. All injections were made through 
this catheter. After each injection the indwelling catheter 
was flushed with heparinized saline to complete administra-
tion of all materials and prevent blood clotting. 
Hemodynamic parameters and respiration were monitored 
. 3 with a Beckman Type R dynograph recorder • One channel ·was 
1ohio Chemical and Surgical Company, Madison, Wisconsin. 
2sherwood Medical Industries, Inc., St.Louis, Missouri. 
3 Beckman Instruments, Inc., Schiller Park, -Illinois.· 
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l connected to a Statham P23 Db pressure transducer for re-
cording le.ft. carotid artery .blood pressure.· On the second 
channel, the electrocardiograph (Lead II) was recorded on 
d . h th . 2 each og. A third c annel was connected to a erm1stor 
which was inserted in the endoti:acheal tube to monitor· 
respiration. 
1statham Laboratories, Inc., Hato Rey, Puerto Rico~ 
2 
Klem, R. W. and F. B. Hembrough. Nov. 15, 1966. 
"Inexpensive Monitoring of Cardiovascular and Respiratory 
Functions During Surgery". Journal of American Veterinary 
Medical Association 149: 1297-1302. · · . 
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RESULTS 
Control Dogs 
The effects of intravenously injected E. coli endotoxin 
on the physiological variables of the 6 control dogs .. are 
summarized in Graph l and in Tables l through 10 in the 
Appendix. The average percentage of control values was 
calculated. In Graph l, the systolic blood pressure, heart 
rate, pulse pressure and respiration rate are recorded for. 
the specific time intervals of 3, 12, 21, 30,· 60, and 100 
minutes after endotoxin injection. E. coli endotoxin caused 
the systolic blood pressure to precipitously fall to an 
average .of 40% of the preinjection values in 3 minutes and 
was at 48% and 44% of control values at 30 and 100 minutes, 
respectively. The E. coli endotoxin decreased the heart rate 
and pulse pressure to 56% and 46%. of ·control level. The pulse 
pressure returned to control level and heart rate of 80% 
of control level by 100 minutes. 
Respiration rate varied great~y among animals. In 
some of the animals, especia1ly dog 5 and dog 6, abnormal 
respiratory rhythm and shallow tidal volumes occurred which 
increase the· variability. 
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Choline Chloride Treatment 
Group 
The results of treating dogs in endotoxin shock with 
choline chloride by either infusion or injection are in 
Graphs 2 through 13 and in Tables 11 through 16 in the 
Appendix. Choline chloride infusions and injections did 
elevate the systolic blood pressure initially. After 
initial infusions and injections, the dog's systolic blood 
pressure did not respond well to successive injections as 
seen in Graphs 3, S, 7, 9, 11, and 13. The blood pressure 
of treated dogs 1 and 3 were elevated by choline chloride 
' and remained for extended.periods without additional choline 
chloride (Graphs. 3 and 7). 
The pulse pressure was increased by choline chloride 
administration as seen in Graphs 2, 4, 6, 8, 10, and 12. 
The increase in systolic blood pressure seems related to a 
simultaneous increase in pulse pressure which was sustained 
only in dog I and dog 3. 
Choline chloride did not produce consistent positive 
effects on respiratory rate or hear·t rate. 
During the infusion of the first two experimental dogs, 
skeletal muscular twitching, hypersalivation, hypermotility 
of the intestinal tract, and pulmonary moist rales occurred. 
All subsequent animals were atropinized before being treated 
with choline chloride. In the third, fourth, apd fifth dogs, 
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,• 
twitchings were not prevented by o ;og mg atropine/kg., 
but the other signs fail:ed to occur. .The _sixth dog was given 
1.1 mg at:ropine/kg. Muscular twitchings did not occur;. 
None of -the six animals· 't:i:'e,ated _with choline chlor'ide ,' 
·survived. 
-I 
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DIS<::USSION 
In all dogs, choline chloride infusions or injections 
elevated the systolic bloo(l pressure. However, responses to 
similar dosages ·of administered. choline chloride wer.e not con-· 
sistent. With the two infused dogs, the systolic blood 
pressure remained elevated for extended periods an.d .then 
precipitously dropped. Further infusion failed to elevate 
the systolic blood pressure. With the injected dogs, numerous 
cholirie chloride injections were made maintaining an.elevated 
systolic blood pressure. Extended periods occurred where 
the systolic blood pressure remained elevated without further 
injections. In all dogs but dog number 6, when the systolic 
blood pressure began to decrease after these extended 
periods, additional injections did not elevate the blood 
pressure. In dog number 6 the systolic blood pressure was 
maintained elevated past the 100 minutes when monitoring 
was stopped. When the systolic blood pressure did elevate 
within adequate perfusion pressure, the color of the dog.s' 
mucous membranes did improve markedly in every case, indi-
cating improved vascular perfusion. 
In all experimental dogs the elevation in pulse pressure 
correlates with an elevation of systolic blood pressure. 
This could indicate that the increase in systolic blood 
pressure with oho.line chloride administration is a function 
36 
of increased myocardial cdntractility. Mitchell's study 
(32) supports this hypothesis. He observed that with in-
creased systolic blood pressure an increase in left ventricular 
systolic blood pressure occurred. 
This study revealed that choline chloride produced some 
effects which are similar to nicotinic responses. Small 
dosages' of nicotine stimulate ganglia of the autonomic nervous 
system and smooth and skeletal muscles (20). 'The clinical 
responses are excessive salivation, peristalsis, vomition,. · 
skeletal muscular·twitchings, and an· elevated blciod ·pressure. 
Infusion of choline chloride produced these responses in dogs 
not treated with atropine. Pretreatment with atropine blocked 
excessive salivation, peristalsis, and vomition.. In most dogs 
skeletal muscular twitchings occurred and in all dogs ele-
vated blood pressure occurred initially. 
Furthermore, large dosages of nicotine cause paralysis 
of sympathetic autonomic ganglia (20). This can result in 
dilatation of vessels with a fall of blood pressure. If 
choline chloride produces similar responses as nicotine, 
this could explain the rapidly declining systolic blood 
pressure which occurred in those dogs·after prolonged choline 
chloride treatment. 
A Ln90 9f !· coli endotoxin was chosen for this experi~ 
ment. It is possible that· choline chloride treatment could 
have been beneficial .in treating dogs given a Ln50 • However, 
37 
it is generally thought that successful reversal of shock 
require:;; more attention than single drug treatment. Atten-
tion must be paid to cardiovascular volume, ventilation, 
acid-base balance, and cardiovascular muscle tone. Clinical-
ly, animals in shock are given intravenous, electrolyte-
balanced fluids as determined by central venous pressure. 
Adequate ventilation is ensured by entubating animals when 
necessary. Acidosis is treated with buffers, most commonly 
sodium bicarbonate. Glucocorticoids are given to normalize 
function of blood vessel sphincters. With other supportive 
therapy, choline chloride could be a helpful adjunct in 
successfully reversing endotoxin shock. Low dosages could 
help maintain. systolic blood pressure. A positive inotropic 
effect would· be.advantageous, producing increased.cardiac 
output. 
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SUMMARY 
Endotoxin shock was produced in six control dogs. A LD90 
of E. coli endotoxin was intravenously injected i.nto each 
dog. The initial severe hypotension was followed by a return 
toward normal then the irreversible hypotensive state. 
Choline chloride, a vasopressive drug, was infused 
intravenously to two dogs given ~· coli. The amount of 
choline chloride infused was determined by the systolic blood 
pressure. The four remaining animals in the treated group 
were given periodic intravenous i·njections of choline chloride 
to elevate the systolic pressure. Choline chloride did 
elevate the systolic blood pressure for short time intervals. 
Prolonged administration of choline chloride failed to main-
tain normal systolic blood pressures in the six animals; None 
of the dogs treated with choline chloride survived. 
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APPENDIX 
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Table l. Control dog l 
Systolic Heart Pulse Respiratory Time Blood Rate 
(minutes) Pressure Rate Pressur.e. (breaths/ 
(min Flea:> (beats/min.). 
(mm .. Hg) min .. ) · 
0 llO 120 15 24 
·o.5 110 120 15 21 
1.0 50 92 10 27 
1.5 37 80 7 27 
2.0 37 68 7 40 
3.0 53 72 7 24 
4.0 50 80 5 16 
5.0 50 84 3 24 
6.0 45 8.0 3 24· 
9.0 55 .· 80 8 . 28 
12.0 57 76 15 .24 
15.0 67 76 17 24 
18. 0 67 80 20 20 
21.0 65 80 20 20 
24.0 65 82 20 20 
27.0 65 80 21 24 
30.0 67 82 21 20 
33.0 67 80 22 20 
40.0 70 80 20 24 
50.0 57 88 22 20 
60.0 55 82 20 20 
70. 0 55 88 ·20 .24 
80 .o 50 96 20 24 
90.0 50 96 20 24 
100.0 50 96 20 24 
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Table 2. Control dog 2 
Systolic Heart Pulse Respiratory Time Blood Rate Pressure Rate (minutes) Pressure (beats/min.) (mm .Hg) (breaths/ (mm' Hg) min.) 
0 170 148 45 28 
0.5 130 144 37 16 
1.0 ·60 128 23 polypnea 
1.5 47 112 20 polypnea 
2.0 46 96 15 . po·lypnea 
3.0 55 88 20 12 
4.0 67 96 21 16 
5.0 71 100 27 16 
6.0 76 10.4 26 12 
9.0 67 104 26 polyp11ea 
12.0 63 104 23 polypnea 
15;0 62 108 21 p9lypnea 
18. 0 58 108 20 40 
21.0 58 108 22 32 
24.0 63 108 24 32 
27.0 65 112 25 32 
30.0 73 112 26 32 
33.0 80 112 30 32 
40.0 
50.0 90 112 40 24 
60.0 93 120 45 .24 
70.0 94 120 45 24 
80.0 95 120 50 24 
90.0 95 116 50 22 
100.0 90 116 50 22 
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Table 3. Control dog 3 
.Systolic Heart ·Pulse 
Respiratory 
Time Blood Rate 
(minutes) Pressure Rate ·Pressure (breaths/ 
(mm .H!i[) · (beats/min. ) (mm Hg) min. l 
0 160 128 28 .20 
0.5 185 132 28 24 
1.0 120 124 25 apnea 
1.5 75 68 30 . 28 
2.0 75 52 30 32 
3.0 70 56 25 arhythmia 28 
4.0 70 52 21 _arhythmia 28 
5.0 73 64 22 arhythmia 28 
6.0 75 60 22 arhythmia 28 
9.0 75 72 25 32 
12.0 75 BO 22 28 
1'5. 0 75 B8 23 28 
18.0 73 B8 23 2B 
21. 0 75 92 23 2B 
24.0 77 92 23 24 
27. 0 B2 96 23 28 
30.0 B2 100 27 24 
33.0 B5 96 32 22 
40 .• 0 BO 104 30 20 
50 .• 0 75 110 30 lB 
60.0 75 110 30 lB 
70.0 75 110 30 20 
BO.O 75 110 30 20 
90.0 75 110 30 20 
100.0 75 110 30 20 
48 
Table 4. Control dog 4 
Systoli_c Heart Pulse 
Respiratory 
Time Blood Rate . Pressure 
Rate 
(minu te·s) Pressure . (breaths/ 
(rnni Hg). (bea ~s/min. ) (min Hg) min.)· 
0 . 95 128 30 2.8 
0.5 85 128 30 20 
1.0 55 112 16 24 
1.5 55 100 15 28 
2.0 55 96 13 32 
3.0 45 96 10 36 
4.0 . 47 92 7 36 
5.0 52 100 10 40 
6.0 .50 108 10 40 
9.0 55 108 13 24 
12.0 57 108 13 24 
15.0 60 100 13 20 
18.0 63 104 17 24 
21. 0 65 104 18 24 
24. 0 65 108 18 20 
27.0 68 104 17 20 
30.0 68 108 16 20 
33.0 63 108 16 20 
40.0 57 112 17. 20 
50.0 57 112 17 20 
60.0 57 112 17 . 20 
'io.o 
80.0 
90.0 
100.0 
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Table 5. Control dog 5 (dog survived) 
Systolic. Heart Pulse 
Respiratory 
Time Blood Rate 
(minutes) Pressure Rate Pressure. (breaths/ 
(mm H~) (beats/min~) (mm Hg) min.) 
0 125 124 25 12 
0.5 130 120 25 8 arhythmia 
1.0 85 132 15 16 arhythmia 
1.5 60 128 15 24 shallow, 
arhythmia 
2.0 40 88 12 40 shallow, 
arhythmia 
3.0 35 60 15 72 shallow, 
arhythmia 
4.0 32 76 12 72 shallow, 
arhythmia 
5.0 35 88 15 60 shallow, 
arhythmia 
6.0 35 92 15 44 shallow, 
arhythmia 
9.0 40 96 15 47 shallow, 
arhythmia 
12.0 40 96 15 47 shallow, 
arhy.thmia 
15.0 
18. 0 
21. 0 40 120 15 40 
24.0 
27.0 
30.0 52 114 20 36 
33.0 
40.0 65 128 20 40 
50.0 67 128 22 52 
60.0 62 128 22 44 
70.0 50 120 22 48 
80.0 45 120 20 64 
90.0 45 134 25 52 
100.0 50 130 23 48 

Table 7. Systolic blood pressure of control dogs 
Post Control Animals verage Endo toxin Dog 1 Dog 2 Dog 3 Dog 4 Dog 5 Dog 6 
Per cent 
Time of control 
(min.) (mm Hg) (mm Hg) (~Hg) (mm Hg) (mm Hg) (mm Hg) value 
0 110 170 160 95 125 145 %4-SD -
3 53(48.2)a 55(32.4) 70(43.7) 45(47.5) 35 (28.0) 40(27.6) 37.8+9.65 
12 57(51.7) 63 (37 .O) 75(46.8) 57 (60 .0) 40(32.0) 22(15.3) 40.5+15.9 
21 65.(59.0) 58(34 .1) 75(46.8) 65(68.5) 40(32.0) 30(23.3) 43.9+17.3 
30 67(60.8) 73(42.9) 82 (51.3) 68(71.5) 52(41.5) 32(22.0) 48.4+17.l 
60 55(50.0) 93 (54.5) 75(46.8) 57(60.0) 62 (49 .5) 35(24.2) 47.5+12.3 
100 50 (.45 .5) 90 (52 .9) 75 (46 .8) 50(39.9) 50(34.5) 43.9+ 7.0 V1 I-' 
a Per cent of control value. 
Table 8. Pulse pressure of control dogs 
Post Control Animals Average Endo toxin Dog 1 Dog 2 Dog 3 Dog 4 Dog 5 Dog 6 Per cent Time of control 
(min.) (mm Hg) (mm Hg) (mm Hg) (mm Hg) (mm Hg) (mm Hg) value 
0 15 45 28 30 25 30 
3 7(46.6) 20 (44 .5) 25(89.3) 10(33.3) 15(60.0) 22(73.3) 57.8+20.7 
12 15 (100 .o l 23(51.2) 22 (78.5) 13(43.4) 15(60.0) 12(40.0) 62.2+23.l 
21 20 (133. 3) 22(48.8) 2.3(82.2) 18 (60 .O) 15(60.0) 13(43.3) 71.3+33.2 
30 21(140.0) 26(57.8) 27 (96 .5) 16 (53.4) 20 (80.0) 15(50.0) 79.6+34.6 
60 20 (133.3) 45 (100.0l 30(100.7) 17 (56. 7) 22(88.0) 20(66.6) 91.9+27.9 
100 20(133.3) 50(111.0) 30 (100. 7) 23(92.1) 17(56.8.) 98.8+28.l U1 "' 
Table 9. Heart rate of control dogs 
Post 
Control Animals 
Average 
Endo toxin 
Dog 1 Dog 2 Dog 3 Dog 4 Dog 5 Dog 6 
Per Cent 
Time of control 
(min.) (mm Hg) (mm Hg) (mm Hg) (mm Hg) (nun Hg) (mm Hg) value 
0 120 148 128 128 124 160 
3 72(60.0) 88(59.5) 56(43.8) 96 (75 .0) 60 (48.3) 88(55.0) 56.9+10.8 
12 76 (63.3) 104(70.3) 80(62.5) 108(84.4) 96 (77 .4) 84(52.5) 68.4+11.4 
21 80(66.7) 108(73.0) 92 (71.8) 104 (81.3) 120(96.8) 108(67.5) 76.2+11.4) 
30 82 (68.3) 112(75.7) 100(78.0) 108(84.4) 114(92.0) 124(77.5) .79.3+ 8.1 
60 82(68.3) 120 (81.1) 110(86.0) 112(87.5) 128(103.0) 136(85.0) 85.2+11.2 
100 96(80.0) 116(78.4) 110(86.0) 130(104.8) 128(80.5) 85.9+10.9 
U1 
"' 
Table 10. Respiratory rate of control dogs 
Post Control Animals Average Endo toxin Dog 1 Dog 2 Dog 3 Dog 4 Dog 5 Dog 6 Per Cent Time of control 
(min. l (mm Hg) (mm Hg) (mm Hg) (mm Hg) (mm Hg) (mm Hg) value 
0 24 28 20 2 Ii 12 12 
3 24 (100.0l 12(42.8) 28(140.0) 36(128.5) 72(600.0) 80(666.0) 279.5+276.6 
12 24 (100 .0) 60(212.0) 28(140.0) 24(85.7) 47 (391.0) 56(466.0)· 232.5+159.8 
21 20(83.4) 32(114.0) 28(140.0) 24(85.7) 40(333.0) 36 (298.0) 175.7+110.8 
30 20(83.4) 32(114.0) 24(120.0) 20(71.4) 36 (298.0) 24 (200.0). 147.8+86.2 
60 20(83.'1.) 24(85.7) 18(90.0) 20(71.4) 44 (366.0) 20(167.0) 143.9+114.0 
100 24(100.0) 22(77.5) 20 (100 .0) 48(400.0) 16 (133.0) 162.1(134.4) 
V1 ... 
Table 11. Choline chloride treated dog l 
Post systolic Heart Pulse Respiratory Endo toxin Remarks· Blood Rate Pressure Rate Time Pressure (beats/ (mm Hg) (breaths/ (minutes) (mm H~il) min.) min.) 
0 119 114 47 15 
3 51(42.8)a 108 27(57.5) 30 
12 55(46.2) 96 15 (31.9) 30 
21 5.0 mg choline chloride per 67(56.3) 84 26(55.4) 8 arhythmic 
kilograrn body weight intra- shallow 
venously 
25 80 (67 .1) 84 33(70.2) 20 arhythmia 
33 67(56.3) 84 26(55.4) 8 U1 U1 
35 6.2 mg choline chloride per 67(56.3) 84 26 (55 .4) 8 
kilogram body weight per 
minute intravenously 
37 10.4 mg choline chloride 67(56.3) 84 26(55.4) 8 
per kilogram body weight 
per minute intravenously 
40 100(84) 98 50(106) 8 arhythmic 
apnea 
occurred 
periodically 
aPer cent of control. 
Table 11 (Continued) 
J?ost 
End.otoxin 
Time 
(minutes) 
43 
63 
Remarks 
Infusion reduced to 6.2 
mg choline chloride per 
kilogram body weight 
Systolic 
Blood 
Pressure 
(mm Hf) 
100(84-
Hypersalivation, vomition, 100(84) 
skeletal muscular twitch-
ing, hyper peristalis 
occurred. Mucous membrane 
color improved 
63 Infusion stopped at this 
time 
108 Hypersalivation, skeletal 100(84) 
muscular twitching, hyper-
peristalsis continued. 
Mucous membrane color 
deteriorated. No electro-
cardiographic abnormalities 
occurred. The dog died 2 
hours after infusion was 
stopped 
Heart Pulse Rate Pressure (beats/ (mm Hg) min.) 
98 50(106) 
98 50(106) 
81 53(122.8) 
Respiratory 
Rate 
(breaths/ 
min.) 
8 
8 arhythmic 
l11 
"' 
Table 12. Choline chloride treated dog 2a 
Post Systolic Heart Pulse Respiratory Endo toxin Blood Rate Rate 
Time Remarks Pressure (beats/ Pressure (breaths/ 
(minutes) (mm Hg:J min.) 
(mm Hg) min.) 
0 132 132 30 19 
3 47(35.6) 102 15(50) 30 
12 65(49.3) 80 25(83.3) 27 
20 5.0 mg choline chloride 57(43.2) 120 22 (73.4) 18 
per kilogram body weight 
per minute 
21 125(94.7) 150 50(166.5) 18 arhythmia 
23 The color of mucous mem- 75(56.7) 96 30(100) 15 arhythmia 
branes improved. A force-
U1 
-..! 
ful urination occurred. 
13.2 mg choline chloride 
per kilogram body weight 
per minute intravenously 
24 100 (75. 7) 84 40(133) 9 arhythmia 
25 Pulmonary moist rates hy-100(75.7) 84 40(133) 9 arhythmia 
persalivation occurred. 
10.0 mg choline chloride 
per kilogram body weight 
per minute intravenously 
26 100 (75. 7) 72 37(123.2) 9 arhythmia 
shallow 
aFurther infusion of choline chloride failed to elevate the blood pressure. 
The dog died in two hours. 
Table 12 (Continued) 
Post 
Endo toxin 
Time 
(minutes) 
31 
34 
46 
·Remarks 
Systolic 
Blood 
Pressure 
(mm Hg) 
In.fusion stopped 
Skeletal muscular twitch-
ing and intestinal hyper-
mobili ty was prominent 
Rapid drop in systolic 
blood pressure with rapid 
drop in pulse pressure at 
this tiine. Electrocardio-
graphic abnormalities also 
occurred 
115(87.1) 
145(110) 
145 (110) 
Heart 
Rate 
(beats/ 
min.) 
66 
72 
72 
Pulse 
·Pressure 
(mm Hg) 
55(183.3) 
65 (216 .2) 
65(216.2) 
Respiratory 
Rate 
(breaths/ 
min.) 
5 arhythmia 
·shallow 
apnea 
shallow 
olignea 
lJ1 
"' 
Table 13. Choline chloride treated dog 3 
Post Systolic Heart Pulse Respiratory Endo toxin Remarks Blood Rate Pressure Rate Time Pressu.re (beats/ (breaths/ 
(minutes) (mm Hg) min .• ) (mm Hg) min.) 
0 152 132 20 12 
3 50(32.9) 90 10(50) 36 
12 30 (19. 7) 136 15(75) 
10 apnea 
bagged animal 
20 Injections: 0.9 mg 47(30.8) 138 10 (50) 36 
atropine per kilogram 
intravenously 
25 Injection: 5 .0 mg cho- 47(30.8) 138 10(50) 36 
line chloride per kilo-
gram intravenously 01 
\D 
25,40 sec. 95(62.5) 132 12(60) 66 
25,50 sec. 80(52.6) 132 12 ( 6 0) 36 
28 Injection: 5.0 mg cho- 50(32.9) 132 12(60) 36 
line chloride per kilo-
gram intravenously 
28,40 sec. 63 (41.4) 132 12(60) 60 
30,30 sec. Injection: 6 .0 mg cho- 50(32.9) 132 . 12 (60) 36 
line chloride per kilo-
gram intravenously 
32 Injection: 10 mg cho- 55(36.2) 132. 12(60) 36 
line ghloride per kilo-
gram intravenously 
Table 13 (Continued) 
Post Systolic Heart Pulse Respiratory Endotoxin Blood Rate Pressure Rate Time Remarks Pressure (beats/ (mm Hg) (breaths/ (minutes) (mm Hsl min • l min.) 
35 Injection: 10.0 mg choline 55(36.2) 132 12 ( 6 0) 36 
chloride per kilogram 
intravenously 
38 Skeletal muscular twitching 85(55.8) 126 22(110) 36 arhythmia 
occurred shallow 
43 100(65.7) 108 25 (125) 36 arhythmia 
shallow 
47 Injection: 5.0 mg choline 75(49.3) 108 25 (125) 36 arhythmia 
chloride per kilogram shallow 
intravenously 
"' 47,20 sec. 90(59.2) 108 25(125) 36 arhythmia 0 
shallow 
48 75(49.3) 108 25(125) 36 arhythmia 
shallow 
56 Injection: 5 .0 mg choline 90(59.2) 108 25(125) 36 arhythmia 
chloride per kilogram intra- shallow 
venously. Mucous membrane 
color improved. Skeletal 
muscular twitching occurred. 
56,20 sec. 110(72.4) 114 25 (125) 36 arhythmia 
shallow 
Table 13 (Continued) 
Post 
Endo toxin 
Time 
(minutes) 
Remarks 
96 A precipitous fall in blood 
pressure occurred. Further 
choline chloride injections 
Systolic 
Blood 
Pressure 
(mm Hg) 
110.(72 .4) 
of 5.0 mg per pound and 10.0 
mg per kilogram failed to 
elicit any response. The dog 
died in four hours. Muscular 
twitching was not inhibited by 
atropinizing the dog. Hyper-
salivation, moist pulmonary 
rales, and hyperperistalsis 
was not observed, however. 
Heart 
Rate 
(beats/ 
min.) 
114 
Pulse 
Pressure 
(mm Hg) 
25(125) 
Respiratory 
Rate 
(breaths/ 
min.) 
36 arhythmia 
shallow 
Table 14. Choline chloride treated dog 4 
Post, systolic Heart Pulse Respiratory Endo toxin Remarks Blood Rate Pressure .Rate Time Pressure (beats/ (mm Hg) (breaths/ (minutes) (mm Hg) min.) min.) 
0 155 126 40 12 
3 40(25.6) 108 25(62.5 polypnea 
12 40(25.6) 114 7(17.5) 36 
20 Injection: 0.9 mg atro- 37(23.7) 120 25(62.5) 20 
pine per kilogram body 
weight intravenously 
25 Injection: 5 .o mg cho,- 37(23.7) 120 25(62.5) 20 
line chloride per kilogram 
body weight intravenously 
26 117(75.5) 120 25(62.5) 20 
"' 27 Injection: .5.0 mg cho- 37(23.7) 120 25(62.5) 20 "' 
line chloride per kilo-
gram body weight intra-
venously 
28,30 sec. 135 (87 .1) 120 45(112.5) olignea shal-
low arhythmia 
29 Injection: 5.0 mg cho- 37(23.7) 120 25(62.5) 20 
line chloride per kilo-
gram body weight intra-
venously 
29,15 sec. 120 (77 .5) 124 37(92.5) 22 shallow 
30,5 sec. Injection: 5 .O mg cho- 55(35.3) 108 25(62.5) polypnea 
line chloride per kilo-
gram body weight intra-
venously 
Table 14 (Continued) 
Post Systolic Heart Pulse Respiratory Endo toxin Remarks Blood Rate Pressure Rate Time Pressure (beats/ (mm Hg) (breaths/ (minutes) (mm H9) min.) min.) 
30,20 sec;:. 115 (74. 2) 120 40(100) 40 shallow 
31,5 sec. Injection: 5. 0 mg choline 65 (41.9) 108 25(62.5) polypnea 
chloride per kiligram body 
weight intravenously 
31,15 sec. 100(64.5) 108 45(112.5) polypnea 
31,45 sec. Injection: 5.0 mg choline 70(45.2) 101 30(75) polypnea 
chloride per kilogram body 
weight intravenously 
32 100(64.5) 108 30(75) 28 shallow 
32,40 sec. Injection: 5 • 0 mg choline 65(41.9) 108 30(75) 24 shallow 
"' chloride per ~ilogram body w 
weight intravenously. The ' 
color of mucous membranes 
greatly improved. Skeletal 
muscular twitching occurred 
at this time 
32,50 sec. 100(64.5) 108 50(125) 28 shallow. 
33,35 sec. Injection: 5 .O mg choline 65(41.9) 100 35(87.5) 28 shallow 
chloride per kilogram body 
weight intravenously 
33,50 sec. 90 (58.1) 100 50(125) 24 shallow 
34,30 sec. Injection: 5 .O mg choline 55 (35 .5) 100 30 (75) 28 shallow 
chloride per kilogram body 
weight intravenously 
34,50 ·sec. 85 ( 5 4. 8) 96 50(125) 32 shallow 
Table 14 (Continued) 
Post Systolic Heart Pulse Respiratory Endo toxin Remarks Blood Rate Pressure Rate Time Pressure (beats/ (mm Hg) (breaths/ (minutes) (mm HSI) min.) min.) 
35,25 sec. . Injection: 5. 0 mg choline 60(3B.7) 96 35(B7.5) 2B shallow 
chloride per kilogram body 
weight intravenously 
35,45 sec. BS (54. B) 100 50 (125) 2B shallow 
36,20 sec. Injection: 5.0 mg choline 60(3B.7) 92 30 ( 7 5) 24 shallow 
chloride per kilogram body 
weight intravenously 
36,40 sec. 75(4B.4) BB 40(100) 24 shallow 
37,25 sec. Injection: 100 mg choline 65(41.9) BO 30(75) 24 shallow 
chloride per kilogram body 
weight intravenously 
"' 3B 75 (4B:4) B4 40(100) 24 shallow ... 
3B,40 sec. Injection: 10 • 0 mg choline 65(41.9) BO 35(B7.5) 24 shallow 
chloride per kilogram body 
weight intravenously 
39 BO(Sl.6) BO 40(100) 24 shallow 
39,35 se.c. Injection: 10. O mg choline 65(41.9) BO 30(75) 24 shallow 
chloride per kilogram body 
weight intravenously 
40 BO(Sl.6) BO 40(100) 24 shallow 
40,40 sec. Injection: 10.0 mg choline 
chloride per kilogram body 
75(4B.4) 72 30(75) 24 shallow 
weight intravenously. No 
response. The color of mucous 
meml:>rane remains good, but 
skeletal muscular twitching 
became prominent 
-------
Table 14 (Continued) 
Post 
Endo toxin 
Time -
(minutes) 
70 
Remarks 
Injection: 10. 0 mg choline 
chloride per kilogram body 
weight intravenously. No 
response to further injec-
tions of choline chloride 
occurred. The dog was -
euthanized when the blood 
pressure started dropping 
precipitously. Hypersali-
vation, moist pulmonary rales, 
and hyperperistalsis was not 
observed 
Systolic Heart 
Blood Rate 
Pressure (beats/ 
(mm Hg) min.) 
75(48.4) 72 
Pulse 
Pressure 
(mm Hg) 
30 (75) 
Respiratory 
Rate 
(breaths/ 
min.) 
24 shallow 
"' U1 
Table 15. Choline chloride treated dog 5 
Post Systolic Heart Pulse Respiratory Endo toxin Remarks Blood Rate Pressure Rate Time Pressure (beats/ . (mm Hg) (breaths/ (minutes) (mm Hg) min.) min.) 
0 147 138 30 24 
3 35(23.8) 126 9 ( 30) polypnea 
12 50 (34.0) 98 12(40) 96 
20 Injection: 0.9 mg atro- 55(37.4) 98 12(40) 96 
pine per kilogram body 
weight intravenously 
25 Injection: 5.0 mg choline 55(37.4) 98 12(40) 96 
chloride per kilogram body 
weight intravenously 
26 190(129) 180 22(73.3) 36 "' 
34 Injections: 5.0 mg choline 58(39.5) 120 15(50) "' 96 
chloride per kilogram body 
weight intravenously 
35 130(88.5) 138 20(66.6) 96 
38 The color of the mucous 77(52.4) 138 20(66.6) 96 
membrane improved. Skeletal 
muscular twitching did 
occur 
48 
77(52.4) 138 17(56.7) 84 
58 77.(52 .4) 138 25(83.7) 90 
68 77(52.4) 138 25(83.7) 90 
78 71 (48 ."3) 138 25(83.7) 81 
88 70(47.6) 138 20(66.6) 81 
Table 15 (Continued) 
Post Systolic Heart Pulse Respiratory Endo toxin Remarks Blood Rate Pressure Rate . Time Pressure (beats/ (mm .Hg) 
(breaths/ 
(minutes) (mm Hg) min.) min.) 
91 Injection: 5.0 mg choline 65(44.2) 138 20(66.6) 81 
chloride per kilogram body 
weight intravenously 
91,20 sec. 80(54.4) 138 22(66.6) 96 
92 Inj e.ction: 10 • 0 mg choline 65(44.2) 138 17(56.7) 96 
chloride per kilogram body 
weight intravenously 
93 105 (71.5) 138 22 (73.5) 90 
94 Injection: 10.0 choline 60(40.8) 138 18(60.0) 54 
chloride per kilogram body 
weight intravenously 
"' 95 110(74.9) 138 22(73.5) 96 ...., 
96 Injection: 10 .0 mg choline 60(40.8) 138 20(66.6) 48 
chloride per kilogram body 
weight intravenously 
97 95(64.6) 138 20(66.6) 96 
99 Injection: 10. 0 mg choline 60(40.8) 138 17(56.7) 72 
chloride per kilogram body 
weight intravenously 
99,45 sec. 85(57.8) 138 22(66.6) 90 
100,50 sec. Hyper alivation, moist pul-
monary rales, or hyperperis-
talsis did not occur. Further 
injection of choline chloride 
failed to elevate the blood 
pressure. The dog died within 
6 hours 
Table 16. Choline chloride treated dog 6 
Post Systolic Heart Pulse Respiratory Endotoxin Blood Rate Rate 
Time Remarks Pressure (beats/ Pressure (breaths/ 
(minutes) (mm Hg) min.) (mm Hg) min.) 
0 155 180 24 
3 50(33.4) 120 30(54.5) 33 
12 50(33.4) 110 25(45.5) 66 
20 Injection: 1.10 mg atro- 50(33.4) 120 22(40.0) 66 
pine per kilogram body 
weight intravenously 
24 Injection: 5.0 mg choline 45(29.0) 136 25(45.5) 64 
chloride per kilogram body 
weight intravenously 
24,30 sec. 75 (48.4) 125 55(100) 72 
"' 25,30 sec. 50(33.4) 132 25(45.5) 72 "" 
28 Injection: 5.0 mg choline 50(33.4) 132 25 (45 .5) 72 
chloride per kilogram body 
weight intravenously 
28,30 sec. 85(54.7) 138 55 (10.0) 72 
30 55(35.4) 138 26(47.3) 84 
38 Injection: 5.0 mg choline 55(35.4) 138 26(47.3) 78 
chloride per kilogram body 
weight intravenously 
38,30 sec., 100(64.5) 132 60(104) 84 
40 65(41.9) 132 33(60) 84 
50 Injection: 5.0 mg choline 70(45.1) 132 35(63.6) 6.6 
chloride per kilogram body 
weight intravenously 
Table 16 (Continued) 
Post SY.stolic Heart Pulse 
Respiratory 
Endo toxin 
Remarks Blood Rate Pressure Rate Time Pressure (beats/ (mm Hg) (breaths/ (minutes) (mm Hg) min. l min.) 
-
50,20 sec. 105(67.7) 140 70 (127) 66 
53 65(41.9) 144 30(54.5) 42 
60 70 (45 .1) 144 3 0 (54. 5) 48 
70 85 (54. 9) 150 55(100) 42 
80 75(48.4) 150 50(90.0) 60 
95 Injection: 5. 0 mg choline 80 (51.6) 156 50(90.9) 54 
chloride per kilogram body 
weight intravenously 
95,20 sec. 115(74.2) 180 65 (118) 36 
"' 96,20 sec. 80(51.6) 166 45 (81;8) 60 "' 
100 No muscular twitching, 75(48.4) 166 40(72.7) 72 
hypersalivation, moist 
pulmonary rales or hyper-
peristalsis was seen. The 
dog died 5 hours later 
